Cargando…

Integrative molecular analysis of metastatic hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is the major type of primary liver cancer. Intrahepatic metastasis, such as portal vein tumor thrombosis (PVTT), strongly indicates poor prognosis of HCC. But now, there are limited understandings of the molecular features and mechanisms of those metastatic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Dongfang, Zhu, Yanjing, Tang, Jing, Lian, Qiuyu, Luo, Guijuan, Wen, Wen, Zhang, Michael Q., Wang, Hongyang, Chen, Lei, Gu, Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854708/ https://www.ncbi.nlm.nih.gov/pubmed/31722693 http://dx.doi.org/10.1186/s12920-019-0586-4

Ejemplares similares

HCCDB: A Database of Hepatocellular Carcinoma Expression Atlas
por: Lian, Qiuyu, et al.
Publicado: (2018)

Recurrently deregulated lncRNAs in hepatocellular carcinoma
por: Yang, Yang, et al.
Publicado: (2017)

Trajectory and Functional Analysis of PD‐1(high) CD4(+)CD8(+) T Cells in Hepatocellular Carcinoma by Single‐Cell Cytometry and Transcriptome Sequencing
por: Zheng, Bo, et al.
Publicado: (2020)

The identification and functional analysis of CD8+PD-1+CD161+ T cells in hepatocellular carcinoma
por: Li, Zhixuan, et al.
Publicado: (2020)

Fast dimension reduction and integrative clustering of multi-omics data using low-rank approximation: application to cancer molecular classification
por: Wu, Dingming, et al.
Publicado: (2015)

ANKFN1 plays both protumorigenic and metastatic roles in hepatocellular carcinoma
por: Wang, Yanyan, et al.
Publicado: (2022)

The Wnt/β-catenin signaling pathway in the tumor microenvironment of hepatocellular carcinoma
por: Wang, Kaiting, et al.
Publicado: (2022)

Immune-associated molecular occurrence and prognosis predictor of hepatocellular carcinoma: an integrated analysis of GEO datasets
por: Liu, Guanjun, et al.
Publicado: (2021)

An 8-gene predicting survival model of hepatocellular carcinoma (HCC) related to pyroptosis and cuproptosis
por: Wang, Hongjin, et al.
Publicado: (2023)

A Prognostic Gene Signature for Hepatocellular Carcinoma
por: Chen, Rong, et al.
Publicado: (2022)

Association between subclinical hyperthyroidism and a PRKAR1A gene variant in Carney complex patients: A case report and systematic review
por: Wang, Hongyang, et al.
Publicado: (2022)

Imaging biomarkers on Angio-CT for predicting the efficacy of transarterial chemoembolization in hepatocellular carcinoma
por: Wang, Haochen, et al.
Publicado: (2023)

Molecular Targets of Ferroptosis in Hepatocellular Carcinoma
por: Liao, Hao, et al.
Publicado: (2021)

Key Candidate Prognostic Biomarkers Correlated with Immune Infiltration in Hepatocellular Carcinoma
por: Deng, Zenghua, et al.
Publicado: (2021)

A Molecular Hepatocellular Carcinoma Prognostic Score System Precisely Predicts Overall Survival of Hepatocellular Carcinoma Patients
por: Jia, Jie, et al.
Publicado: (2022)

Novel biomarker genes for the prediction of post-hepatectomy survival of patients with NAFLD-related hepatocellular carcinoma
por: Song, Yuting, et al.
Publicado: (2023)

Molecular Scoring of Hepatocellular Carcinoma for Predicting Metastatic Recurrence and Requirements of Systemic Chemotherapy
por: Nishida, Naoshi, et al.
Publicado: (2018)

Vitamin C preferentially kills cancer stem cells in hepatocellular carcinoma via SVCT-2
por: Lv, Hongwei, et al.
Publicado: (2018)

Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma
por: Yang, Liu, et al.
Publicado: (2018)

Inhibition of Metastatic Hepatocarcinoma by Combined Chemotherapy with Silencing VEGF/VEGFR2 Genes through a GalNAc-Modified Integrated Therapeutic System
por: Li, Xunan, et al.
Publicado: (2022)

Metastatic Hepatocellular Carcinoma to Parotid Glands
por: Elzouki, Abdel-Naser, et al.
Publicado: (2014)

Radiotherapy for Metastatic Fibrolamellar Hepatocellular Carcinoma
por: G. Peacock, Justin, et al.
Publicado: (2013)

Metastatic Fibrolamellar Hepatocellular Carcinoma to the Pancreas
por: Villa, Nicolas A., et al.
Publicado: (2015)

Metastatic Hepatocellular Carcinoma Responsive to Pembrolizumab
por: Truong, Phu, et al.
Publicado: (2016)

Complete remission in metastatic hepatocellular carcinoma
por: Ben Kridis, Wala, et al.
Publicado: (2023)

Molecular heterogeneity in hepatocellular carcinoma
por: Zhu, Shijia, et al.
Publicado: (2018)

Construction of a prognosis-predicting model based on autophagy-related genes for hepatocellular carcinoma (HCC) patients
por: Zhu, Yayun, et al.
Publicado: (2020)

Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma
por: Zhao, Ling-Hao, et al.
Publicado: (2016)

Recent progress in molecular mechanisms of postoperative recurrence and metastasis of hepatocellular carcinoma
por: Niu, Zhao-Shan, et al.
Publicado: (2022)

Increased expression of LncRNA BANCR and its prognostic significance in human hepatocellular carcinoma
por: Zhou, Tao, et al.
Publicado: (2016)

Integrated analysis of ceRNA network in hepatocellular carcinoma using bioinformatics analysis
por: Luo, Yu, et al.
Publicado: (2021)

Recurrent HBV Integration Targets as Potential Drivers in Hepatocellular Carcinoma
por: Lin, Selena Y., et al.
Publicado: (2021)

Comprehensive analysis of complement-associated molecular features in hepatocellular carcinoma: Complement-associated molecular features in hepatocellular carcinoma
por: Huang, Run, et al.
Publicado: (2022)

Integrative Characterization of Immune-relevant Genes in Hepatocellular Carcinoma
por: Hong, Wei-Feng, et al.
Publicado: (2021)

Identification of HBV-MLL4 Integration and Its Molecular Basis in Chinese Hepatocellular Carcinoma
por: Dong, Hua, et al.
Publicado: (2015)

Molecular characterization of long-term survivors of hepatocellular carcinoma
por: Shen, Junwei, et al.
Publicado: (2021)

Precision oncology and molecular therapies for hepatocellular carcinoma
por: Chen, Liming, et al.
Publicado: (2022)

Quality Assessment of Clinical Practice Guidelines on the Treatment of Hepatocellular Carcinoma or Metastatic Liver Cancer
por: Wang, Yingqiang, et al.
Publicado: (2014)

Targeted sequencing reveals the mutational landscape responsible for sorafenib therapy in advanced hepatocellular carcinoma
por: Tang, Jing, et al.
Publicado: (2020)

Erratum: Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma
por: Zhao, Ling-Hao, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_nvn3iqive4bdl6hsuugom98bsu